Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fabiola Atzeni, Rossella Talotta, Valeria Nucera, Francesca Marino, Elisabetta Gerratana, Donatella Sangari, Ignazio Francesco Masala & Piercarlo Sarzi-Puttini. (2018) Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors. Expert Review of Clinical Immunology 14:11, pages 945-956.
Read now
Read now
Articles from other publishers (6)
Leila Kooshki, Seyede Nazanin Zarneshan, Sajad Fakhri, Seyed Zachariah Moradi & Javier Echeverria. (2023) The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids. Phytomedicine 112, pages 154686.
Crossref
Crossref
Chen Li, Wanting Yin, Ning Yu, Dongmei Zhang, Haijiao Zhao, Jingbo Liu, Junchao Liu, Yaping Pan & Li Lin. (2019)
miR‐155 promotes macrophage pyroptosis induced by
Porphyromonas gingivalis
through regulating the NLRP3 inflammasome
. Oral Diseases 25:8, pages 2030-2039.
Crossref
Crossref
Sara La Manna, Laura Lopez‐Sanz, Marilisa Leone, Paola Brandi, Pasqualina Liana Scognamiglio, Giancarlo Morelli, Ettore Novellino, Carmen Gomez‐Guerrero & Daniela Marasco. (2018) Structure‐activity studies of peptidomimetics based on kinase‐inhibitory region of suppressors of cytokine signaling 1. Peptide Science 110:5, pages e23082.
Crossref
Crossref
Zhenxing Liang, Guiling Wu, Chongxi Fan, Jing Xu, Shuai Jiang, Xiaolong Yan, Shouyin Di, Zhiqiang Ma, Wei Hu & Yang Yang. (2016) The emerging role of signal transducer and activator of transcription 3 in cerebral ischemic and hemorrhagic stroke. Progress in Neurobiology 137, pages 1-16.
Crossref
Crossref
Fransien van Dijk, Peter Olinga, Klaas Poelstra & Leonie Beljaars. (2015) Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma. Frontiers in Medicine 2.
Crossref
Crossref
Chulbul M. Ahmed & Howard M. Johnson. (2014) Type I Interferon Mimetics Bypass Vaccinia Virus Decoy Receptor Virulence Factor for Protection of Mice against Lethal Infection. Clinical and Vaccine Immunology 21:8, pages 1178-1184.
Crossref
Crossref